Moreover, since the CXCL12/CXCR4 oncogenic bridge serves as communication between tumor cells and stromal cells, numerous molecules targeting CXCL12/CXCR4 signaling have been developed to interfere with tumor growth [147]. The gene discussed is CXCR4; the disease is neoplasm.